Step 1 topics → Renal → Carbonic Anhydrase Inhibitors (Acetazolamide)

Carbonic Anhydrase Inhibitors (Acetazolamide)

USMLE Step 1 trap: Confuses acetazolamide as causing metabolic alkalosis rather than hyperchloremic metabolic acidosis. Acetazolamide causes hyperchloremic non-anion-gap metabolic acidosis by blocking HCO3 reabsorption in the proximal tubule, leading to urinary bicarbonate wasting.

Acetazolamide is a carbonic anhydrase inhibitor that blocks the proximal tubule's ability to reabsorb bicarbonate — and USMLE Step 1 tests it through a trap that catches most students: unlike furosemide and thiazides, acetazolamide causes a hyperchloremic non-anion-gap metabolic acidosis, not alkalosis, because it wastes bicarbonate in the urine rather than retaining it. It blocks the enzyme that converts CO2 + H2O into H2CO3 in the proximal tubule, so HCO3- spills into the urine. The downstream tubule segments compensate for the lost sodium and water, which is why it is a weak diuretic — most of what it dumps gets reclaimed later.

Step 1 will give you a patient on acetazolamide and ask you to predict the acid-base status, or give you a clinical scenario and ask which diuretic is appropriate. The other trap is that students only remember acetazolamide for one indication (usually altitude sickness) and miss that it shows up across multiple organ systems — glaucoma, idiopathic intracranial hypertension, and urinary alkalinization for aspirin toxicity are all tested indications.

Recognizing that this drug's value comes from its HCO3-wasting effect — not from powerful volume reduction — is the core insight that connects all of its clinical uses.

From real student decks
59%have cards covering this topic
46%have mature cards
1.0median lapses in 14 days

Common misconceptions

Common mistake
Wrong: Acetazolamide causes metabolic alkalosis because it is a diuretic like loop diuretics.
Right: Acetazolamide causes hyperchloremic non-anion-gap metabolic acidosis by blocking HCO3 reabsorption in the proximal tubule, leading to urinary bicarbonate wasting.
Loop diuretics and thiazides cause metabolic alkalosis because they waste Cl- and volume-contract the patient, which drives HCO3- retention. Acetazolamide does the opposite — it directly blocks bicarbonate reabsorption in the proximal tubule, so HCO3- is lost in the urine. This leaves the blood with relatively more Cl- and less buffer, producing a hyperchloremic non-anion-gap metabolic acidosis. If a Step 1 vignette mentions acetazolamide and asks about acid-base status, the answer is acidosis, not alkalosis.
Common mistake
Gap: Missing the multi-system clinical indications for acetazolamide beyond its renal effects
Acetazolamide has diverse indications including open-angle glaucoma (reduces aqueous humor production), altitude sickness prophylaxis, idiopathic intracranial hypertension, and alkalinizing urine to treat certain drug toxicities.
Carbonic anhydrase is active in multiple tissues beyond the kidney — in the ciliary body of the eye it drives aqueous humor production, and in the choroid plexus it contributes to CSF production. Blocking it with acetazolamide reduces aqueous humor (treating open-angle glaucoma), reduces CSF pressure (treating idiopathic intracranial hypertension), and alkalinizes the urine (trapping ionized forms of weak acids like salicylates to promote their excretion). Acetazolamide is also used for altitude sickness prophylaxis by pre-emptively inducing a mild metabolic acidosis that stimulates breathing. Knowing these indications as a cluster — not just the altitude one — is what USMLE Step 1 expects.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand why acetazolamide is considered a weak diuretic: blocking proximal tubule carbonic anhydrase prevents HCO3- reabsorption, but downstream segments compensate for most of the sodium and fluid loss.
  2. Predict the acid-base consequence of acetazolamide use: urinary bicarbonate wasting leads to hyperchloremic non-anion-gap metabolic acidosis, not alkalosis.
  3. Recognize the multi-system clinical indications for acetazolamide: open-angle glaucoma (reduces aqueous humor production), altitude sickness prophylaxis, idiopathic intracranial hypertension, and urinary alkalinization for certain drug toxicities (e.g., aspirin overdose).

Can you avoid these mistakes?

A patient taking acetazolamide for open-angle glaucoma comes in for a routine checkup. What acid-base abnormality would you expect on their basic metabolic panel, and what is the mechanism?
A 65-year-old man on acetazolamide for open-angle glaucoma is found to have a normal blood pressure and no edema, but his kidney excretes far less water than furosemide-treated patients at equivalent doses. His colleague on furosemide lost 4 liters in 24 hours; his urine output is only 1 liter. Why is acetazolamide a weak diuretic compared to loop diuretics, given that both act in the kidney?
A hiker heading to altitude wants prophylaxis against acute mountain sickness. You prescribe acetazolamide. A colleague asks how this prevents altitude sickness — what is the physiologic explanation?
A patient presents with aspirin overdose. You consider acetazolamide as part of management. What is the rationale, and what acid-base complication do you need to monitor for if you give it?

Related topics

Renal Acid-Base Handling Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →